1. Home
  2. RVPH vs ABLV Comparison

RVPH vs ABLV Comparison

Compare RVPH & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$2.47

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

ABLV

Able View Global Inc.

N/A

Current Price

$0.69

Market Cap

36.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RVPH
ABLV
Founded
2006
2015
Country
United States
China
Employees
14
89
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
36.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RVPH
ABLV
Price
$2.47
$0.69
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$66.67
N/A
AVG Volume (30 Days)
2.6M
5.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$16.70
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.59
52 Week High
$3.11
$1.77

Technical Indicators

Market Signals
Indicator
RVPH
ABLV
Relative Strength Index (RSI) 75.19 39.23
Support Level $0.32 $0.60
Resistance Level N/A $0.97
Average True Range (ATR) 0.13 0.03
MACD 0.28 -0.01
Stochastic Oscillator 76.53 24.24

Price Performance

Historical Comparison
RVPH
ABLV

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: